Human S100A10 Protein, His Tag
分子別名(Synonym)
S100A10,p11,p10,ANX2LG,CAL1L,CLP11
表達(dá)區(qū)間及表達(dá)系統(tǒng)(Source)
Human S100A10, His Tag (S10-H5127) is expressed from E. coli cells. It contains AA Met 1 - Lys 97 (Accession # AAH15973).
Predicted N-terminus: Met
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 12.0 kDa. The protein migrates as 14 kDa under reducing (R) condition (SDS-PAGE).
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>95% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in 50 mM Tris, 150 mM NaCl, pH8.0 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(chǔ)(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
S100鈣結(jié)合蛋白A10(S100A10)是S100家族的一員,含有兩個(gè)EF手鈣結(jié)合基序,也稱為S100-A10蛋白、鈣帕汀I輕鏈、膜聯(lián)蛋白II的細(xì)胞配體、p10蛋白和p11,可以作為游離單體、同二聚體或由p11二聚體復(fù)合物與兩個(gè)膜聯(lián)蛋白Ⅱ分子組成的異四聚體發(fā)現(xiàn)。S100A10是細(xì)胞結(jié)構(gòu)支架的組成部分,通過與膜聯(lián)蛋白II的結(jié)合與質(zhì)膜蛋白相互作用。S100A10還與細(xì)胞溶質(zhì)和外周膜相關(guān)蛋白(如AHK)一起作用于細(xì)胞內(nèi)膜的發(fā)育。此外,S100A10與情緒調(diào)節(jié)、傷害感受和細(xì)胞極化相關(guān)的蛋白質(zhì)運(yùn)輸有關(guān)。S100A10與膜聯(lián)蛋白II復(fù)合,結(jié)合受體和通道蛋白并將其引導(dǎo)到細(xì)胞表面,導(dǎo)致膜定位增加,從而放大了這些蛋白的功能表達(dá)。
關(guān)鍵字: S100A10;S100A10蛋白;S100A10重組蛋白;ACRO;百普賽斯;
百普賽斯集團(tuán)ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺(tái)型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團(tuán)業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個(gè)城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計(jì)服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團(tuán)旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。